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Adult Blood/ 
Blood Product 
 Infusion Protocol Order 
 
Beginning February 1, 2002, implementation of 
placing the attached Adult Blood/Blood Product 
Infusion Protocol Order in patient charts any 
time blood is ordered for non-surgical patients is 
being requested. 
 
This form was implemented previously but 
discontinued.  It has been revised and now re-
implemented due to a major citation from 
JCAHO.  JCAHO makes us responsible for 
documenting blood administration informed 
consent; that is what they found missing 
during our last survey.  This revised form 
imbeds the necessary informed consent 
documentation, making it automatic without 
requiring another form and another physician 
signature. 
 
The Medical Care Review Committee and the 
Medical Staff Executive Committee have 
approved these changes and support having this 
order placed in patient charts when blood is 
ordered for non-surgical patients.  As always, 
the Medical Staff Executive Committee wants 
to assure compliance with regulatory 
mandates while making their impact on 
physicians as minimally intrusive as possible. 
 
These forms have been printed and are available 
in Distribution. 
 
Submitted by: 
Mary Buhl 
 
 
Pain Assessment,  
Changes in Documentation 
 
All patients must be assessed for pain upon 
admission or upon the first visit.  This includes 
all inpatient units, including Mental Health Unit 
and Recovery Plus.  This standard must also be 
addressed in most outpatient areas.  The 
following steps outline what must be done for 
the assessment and management of pain. 
 
Step 1:  
Screen for the presence of pain. 
Is the patient having pain? 
Is the patient concerned about pain? 
Does the patient have a history of chronic 
pain?   
 
Step 2: 
If the patient answers yes to the above screening 
question, then a comprehensive assessment must 
be completed. 
 
A comprehensive pain assessment includes the 
following parameters: 
• Onset 
• Location 
• Duration 
• Characteristics 
• Aggravating factors 
• Relieving factors 
• Treatment tried 
 
Step 3: 
Establish and individualized pain management 
goal. 
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Step 4: 
If pain is rated > 3/10 or is unacceptable to the 
patient, there will be an intervention to reduce 
pain 
 
Step 5: 
Reassess for the presence of pain after each 
intervention until pain intensity is at or below the 
patient’s goal and then every four hours while 
awake until pain is resolved or until discharge.  
If pain is not improving with appropriate 
interventions, additional measures should be 
taken unless reasons for waiting are indicated. 
 
The systems for documenting this information 
have been revised.   
• The Functional Health Assessment has been 
updated to include the comprehensive pain 
assessment.  (See diagram A) 
• Stickers have been developed for the 
comprehensive pain assessment and 
reassessment (see diagram B and C). 
• The Physical Findings Pain assessment 
screen has been revised in JRS.  (See 
diagram D) 
 
Additional information is available from you 
Education Council Representative and/or the 
person responsible for education in your area.   
 
Pain Assessment 
Kay Greenlee, MSN, RN, CNS 
Coordinator/Clinical Nurse Specialist 
Comprehensive Pain Program 
 
Diabetes Update 
Information on: 
Insulin glargine (Brand name: Lantus).  
 
• Glargine (Lantus) must not be diluted 
or mixed with any other insulin or 
solution, as it may result in a changed 
action, leading to hyper- or 
hypoglycemia. 
 
 
 
 
 
• Note: This product is clear (i.e., it's a 
solution). Be careful not to confuse this 
insulin with other insulins! Because of 
the risk of confusing the name Lantus 
with the name Lente, staff is encouraged 
to call this insulin Glargine 
 
• Typical Glargine schedule:  
- Usually patients will be on Glargine 
at HS, and either Humalog or Regular 
before each meal. This may be 
ordered as a set amount, or as a 
sliding scale amount. 
- Sometimes patients may be on 
Glargine at HS, and pills for diabetes 
during the day. 
 
• Action: Works over 22-24 hours, and has 
no peak.  
 
• Given at bedtime (about 2200). Used for 
long-acting insulin and replaces NPH or 
Ultralente insulin. 
 
• Class: insulin analog. (Modified human 
insulin) 
 
• Route of Administration: subcutaneous.  
 
• Labeling: Lantus® (glargine) has a 
lavender label to help identify the product 
 
• Snacks: Patients using glargine (Lantus) 
often do not need a bedtime snack, as 
there will not be an insulin peak 
occurring during the night. These patients 
will usually not need a mid a.m. or mid 
p.m. snack, either. 
 
 
Submitted by: 
Diabetes Nurse Educators 
  LeAnne Troxel 
  Barb Isaacson 
  Carol Dirks 
  Pat Osburne 
 
 
 
